Guam. Contact Information. Email: Statistics. Technological Capabilities



Similar documents
Georgia. Contact Information. Office: Fax: Statistics. Technological Capabilities

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

New Jersey. Contact Information. Statistics. Technological Capabilities

Idaho. Contact Information. Fax: (208) Statistics. Technological Capabilities

Illinois. Contact Information. Office: Fax: Statistics. Technological Capabilities

Washington. Contact Information. Statistics. Technological Capabilities

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Massachusetts. Contact Information. Statistics. Technological Capabilities

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Alaska Prescription Drug Monitoring Program

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

11/26/2012. Implementation of Florida s PDMP. Disclosure

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

Prescription Drug Monitoring Programs

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

Implementation of Florida s PDMP. Rebecca Poston Program Manager

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:

CURES Prescription Drug Monitoring Program

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform

Prescription Drug Monitoring Program Annual Report

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014

Prescription Drug Monitoring Programs Bill Status Update

Prescription Drug Monitoring Program. A Powerful Tool

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

The Massachusetts Prescription Monitoring Program

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015

DEA's New Proposed Regulations For E-Prescribing

TABLE OF CONTENTS CHAPTER 8 PRESCRIPTION DRUG MONITORING PROGRAM

Pennsylvania s ABC-MAP Program

Medicare Compliance and Fraud, Waste, and Abuse Training

American Indian Health Commission for Washington State October 1, 2015

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program

SCOPE OF PRACTICE FOR ARNPS

PRESCRIPTION MONITORING PROGRAM (PMP)

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC

Fraud Waste and Abuse Training Requirement. To Whom It May Concern:

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

Fraud, Waste & Abuse. Training Course for UHCG Employees

Training Guide for Florida Practitioners and Pharmacists

AMERICAN PSYCHOLOGICAL ASSOCIATION

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

GENERAL INFORMATION: NURSE PRACTITIONER PRACTICE

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

Prescription Drug Abuse Florida s Health Crisis

PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances

UPDATED. Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs

When Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses. November 13, 2002 Washington, DC

Review of Prescription Drug Monitoring Programs in the United States

Drug and Alcohol Testing of Doctors. Medical Negligence Lawsuits. Initiative Statute.

NCPDP Electronic Prescribing Standards

Mandating PDMP participation by medical providers: current status and experience in selected states

Electronic Prescribing In New York State

New Jersey State Legislative Update. Opioid Addiction and Abuse Prevention. Legislative Package Moves Forward

Texas Board of Nursing Update

Preliminary Evaluation of the Prescription Drug Monitoring Program

Drug and Alcohol Testing of Doctors. Medical Negligence Lawsuits. Initiative Statute.

Manual of Instructions

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2006 Compliance

Prescription Drug Monitoring Program Center of Excellence at Brandeis

NOTICES OF PROPOSED RULEMAKING

State of Utah Department of Commerce Division of Occupational and Professional Licensing

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

Transcription:

PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Naval, Cynthia L. - Planner IV 123 Chalan Kareta Mangilao GU 96913-6304 Office: (671) 735-7204 Fax: (671) 734-5556 Email: GPDMP Guam Department of Public Health and Social Services Department of Health http://dphss.guam.gov/content/prescription-drug-monitoring-program deh@dphss.guam.gov cynthia.naval@dphss.guam.gov ASAP Versions Accepted ASAP 1995 ASAP 1997 ASAP 3/2005 ASAP 4/2007 ASAP 4-1/2010 ASAP 4-2/2011 Pharmacy in-state Pharmacy out-state/mail order Pharmacy out-state other Dispensing doctor Contact Information PDMP region: Pinaula, Jeffrey - Program Coordinator IV 123 Chalan Kareta Mangilao GU 96913-6304 Office: (671) 735-7519 Fax: (671) 734-5556 Email: Technological Capabilities Electronic data transmissio Fax data transmission Mail data transmission Media data transmission Required Data Transmitters Veterinarian Veterans Administration Indian Health Services jeffrey.pinaula@dphss.guam.gov Data Transmission Methods Allowed Other data transmission Other: Data Collection Entity: Vendor Vendor name: Optimum Technology Data Storage Entity: Vendor Vendor name: Optimum Technology Report Generation Entity: Vendor Vendor name: Optimum Technology Data Access Method: Web Portal/On-Line Statistics Statistics Year: 2014 DEA Registered Prescribers: 269 State population: 159,358 Data Collection, Storage, Generation and Access Data Access Entity: Vendor Vendor name: Optimum Technology DEA Registered Dispensers: 25 West

Interstate data sharing PMPi Hub RxCheck Hub RxSentry Hub HIE method Other Hub Data Access via Health Information Exchang via Electronic Health Recor via Pharmacy Dispensing Syste Controlled Schedules Monitored Schedule II monitored Schedule III monitored Schedule IV monitored Schedule V monitored Data Collection and Dates Collection frequency: 14 Legislation enacted: 1972; 1998 PDMP operational 2013 Data Sharing List of states involved in sharing: Impediments to data sharing: Our PDMP just began collecting data in 2013. We do not yet feel ready to begin inerstate data sharing. Exact Match Probablistic Match Policies and Procedures Monitor other authority Remove from Monitoring Web 24/7 Fax 24/7 Web Business Hours Fax Business Hours Other Patient Matching Other Substances Monitored Probablistic/Manual Matc Other Match for queries Data Request Methods and Hours of Operation Phone Business Hours Email Business Hours Mail Business Hours In-Person Business Hours Other Law/Rule Website: Law/Statute citation: Title 9 GCA Chapter 67; Section 67.301 Regulation/Rule citation: Dr Shopper law/statute: Pill Mill law/statute: Pain Clinic law/statute: Disclosure law/statute: Data Retention Policy All Information Purged Data Retention Time: Record Retention Details: 6 years Prescriber Information Purged Dispenser Information Purged Relevant Statutes and Rules http://www.guamcourts.org/compileroflaws/index.html Data Retention Patient Information Purged Drug Information Purged Retain De-Identified Data De-Identified Data Retention Details: A public or private entity may obtain any prescription monitoring information insofar as the information is necessary for statistical, research or educational purposes, and insofar as information that can be used to identify a person has been removed.

Required Enrollment - Prescriber Required Enrollment - Dispenser PDMP Required Enrollment and Patient Query Required Patient Query - Prescriber Required Patient Query - Dispenser Required PDMP Enrollment and/or PDMP Query Detai Prescribers required to check PDMP before first prescription for Controled Substances for new patient. Select Data Fields Available Payment method captured Patient Identification captured Person dropping off captured Person picking up captured Ability to id prescriber specialty Prescriber: Dispenser: Regulatory Board: Law Enforcement: Attorney General: Researcher: Patient: Other: Prescriber Access to Patient History Prescriber Access to Own History Dispenser Access to Patient History Dispenser Access to Own History Miscellaneous Capabilities and Policies Authority to release de-identified data Ability to de-identified data Authority to release for epidemiological or educational purposes Engaged in release for epidemiological or educational purposes Required Notification to consumers Mandated Use of Advisory Group Patient Access to Query List Requirements to Query PDMP PDMP Available Reports Available Reports to Selected Requestors Licensing Board Access to Patient History Licensing Board Access to Licensee History Law Enforcement Access to Patient History Law Enforcement Access to Prescriber History Law Enforcement Access to Dispenser History

Requestors and Reports Authorized to Generate Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Medical Examiner/Coroner Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Medically Indigent Program Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State

Requestors and Reports Being Generated Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Medical Examiner/Coroner Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Medically Indigent Program Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State